Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cullinan Therapeutics Inc (NASDAQ: CGEM) closed the day trading at $18.68 up 0.92% from the previous closing price of $18.51. In other words, the price has increased by $0.92 from its previous closing price. On the day, 0.5 million shares were traded. CGEM stock price reached its highest trading level at $18.93 during the session, while it also had its lowest trading level at $18.43.
Ratios:
For a better understanding of CGEM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 28.87 and its Current Ratio is at 28.87. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 01, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On February 15, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $30.Wedbush initiated its Outperform rating on February 15, 2024, with a $30 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 05 ’24 when Michaelson Jennifer sold 8,000 shares for $16.33 per share. The transaction valued at 130,640 led to the insider holds 123,942 shares of the business.
Michaelson Jennifer sold 58,000 shares of CGEM for $1,628,159 on May 06 ’24. The Chief Scientific Officer now owns 129,582 shares after completing the transaction at $28.07 per share. On May 07 ’24, another insider, Michaelson Jennifer, who serves as the Chief Scientific Officer of the company, sold 5,606 shares for $30.06 each. As a result, the insider received 168,516 and left with 129,582 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 1083002880 and an Enterprise Value of 413386624.
Stock Price History:
Over the past 52 weeks, CGEM has reached a high of $30.19, while it has fallen to a 52-week low of $7.64. The 50-Day Moving Average of the stock is 5.36%, while the 200-Day Moving Average is calculated to be 11.26%.
Shares Statistics:
Over the past 3-months, CGEM traded about 797.08K shares per day on average, while over the past 10 days, CGEM traded about 499900 shares per day. A total of 42.90M shares are outstanding, with a floating share count of 38.57M. Insiders hold about 33.47% of the company’s shares, while institutions hold 77.55% stake in the company. Shares short for CGEM as of 1723680000 were 8155846 with a Short Ratio of 10.23, compared to 1721001600 on 7893041. Therefore, it implies a Short% of Shares Outstanding of 8155846 and a Short% of Float of 16.319999.
